| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,660 | 11,066 | 10,876 | 11,616 | | Cost of Revenue | 1,778 | 2,037 | 2,390 | 3,016 | | | Gross Profit |
-
| 9,029 | 8,486 | 8,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,938 | 7,057 | 8,405 | 7,732 | | Non Recurring |
-
|
-
| 669 | 6,370 | | Others | 1,315 | 688 | 2,253 | 431 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,284 | (2,841) | (5,933) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,629 | 1,284 | (2,841) | (5,933) | | Interest Expense | 950 | 986 | 901 | 990 | | Income Before Tax | 679 | 298 | (3,742) | (6,923) | | Income Tax Expense | (140) | (396) | (1,909) | (548) | | Minority Interest |
-
|
-
| 1 | (124) | | | | Net Income From Continuing Ops | 819 | 694 | (1,832) | (6,499) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 819 | 694 | (1,832) | (6,499) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $819 | $694 | ($1,832) | ($6,499) |
|
0.01% Nasdaq 
0.46%
Income Statement
